To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...

The Environmental Protection Agency is allowing entities subject to the Clean Air Act to seek exemptions via email through ...

Referring to a little-known provision, it said power plants and others could write to seek exemptions to mercury and other ...

The Environmental Protection Agency (EPA) has set up a portal allowing polluters to request exemptions to nine Clean Air Act ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, ...

Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...

Abbott is officially bringing the noise—literally—by launching a clinical trial for its new intravascular lithotripsy (IVL) ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...

The WRAPSODY CIE received premarket approval (PMA) from the US Food and Drug Administration (FDA) in December 2024. Merit began commercialization of the device in the United States in January 2025.

Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.